Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
Publication Type:
Journal Article
Authors:
Hermine, O.;
Lefrere, F.;
Bronowicki, J.P.;
Mariette, X.;
Jondeau, K.;
Eclache-Saudreau, V.;
Delmas, B.;
Valensi, F.;
Cacoub, P.;
Brechot, C.;
Varet, B.;
Troussard, X.Source:
N Engl J Med, Volume 347, Issue 2, p.89-94 (2002)
Keywords:
Adult,
Aged,
analysis,
Antiviral Agents,
blood,
clinical trial,
Comparative Study,
complications,
drug therapy,
Epidemiologic Studies,
Female,
France,
genetics,
HCV,
Hepacivirus,
hepatitis,
Hepatitis C,
hepatitis C virus,
Humans,
Infection,
interferon,
Interferon Alfa-2b,
Interferon-alpha,
isolation & purification,
Lymphocytes,
Lymphoma,
Lymphoma,B-Cell,
Male,
methods,
Middle Aged,
Neoplasm Recurrence,Local,
Paris,
pathogenicity,
Patients,
Remission Induction,
Ribavirin,
Rna,
Rna,Viral,
Splenic Neoplasms,
therapeutic use,
therapy,
Time,
treatment,
virology
